...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Radioanalytical and Nuclear Chemistry: An International Journal Dealing with All Aspects and Applications of Nuclear Chemistry >Production of Re-186g radionuclide by deuterons for theragnostic medicine
【24h】

Production of Re-186g radionuclide by deuterons for theragnostic medicine

机译：氘核用于合成疗法药物的Re-186g放射性核素的生产

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Theragnostic medicine is a new integrated therapeutic system which can diagnose, deliver targeted therapy, and monitor the response to therapy. Many of the "neutron-rich" radionuclides suitable for metabolic radiotherapy are produced by nuclear reactor with a very low specific activity (A (S)). In selected cases, they can be produced by bombardment of targets by charged particle beams in "No Carrier Added Form" with very high A (S). If the irradiations are made with deuteron beams some more advantages are obtained, as described in this paper, through Re-186g production, reported as an example.
机译：Theragnostic医学是一种新型的综合治疗系统，可以诊断，提供针对性的治疗并监测对治疗的反应。许多适于代谢放疗的“富中子”放射性核素都是由核反应堆产生的，其比活度非常低（A（S））。在某些情况下，可以通过以“无载流子形式”以很高的A（S）对带电粒子束轰击目标来产生它们。如果使用氘核束进行辐照，则可以通过Re-186g的生产获得更多的优势，如本文所述（以本文为例）。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号